Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

4021 - 4030 of 5819 results found

Tocilizumab for the treatment of COVID-19

Date
Friday, June 16, 2023 - 4:00 AM
Description
INTRODUCTION: Since the beginning of the COVID-19 pandemic, the repurposing of medicines has been pursued to find interventions effective in preventing fatal outcome of the disease. One of these drugs was tocilizumab, an interleukin-6 inhibiting

Tachykinins and the potential causal factors for post-COVID-19 condition

Date
Friday, June 16, 2023 - 4:00 AM
Description
The most prevalent symptoms of post-COVID-19 condition are pulmonary dysfunction, fatigue and muscle weakness, anxiety, anosmia, dysgeusia, headaches, difficulty in concentrating, sexual dysfunction, and digestive disturbances. Hence, neurological